JAAD – Prevalence of Female Pattern Hair Loss in a Multiracial Population
April 2021
Hélio Amante Miot, Paulo Müller Ramos, Giuliane Tsitsui
We don't know much about this study yet.
We're maintaining the world's largest resposity of hair loss
research. You can help out the community by
sending a PDF of this study here
.
Not sure how to get a study's PDF? You can email the authors
of the study.
The user is experiencing a strange hairlosspattern despite using dutasteride for 3 years and minoxidil with tretinoin for 1.5 years. They recently added microneedling and are considering a scalp biopsy to understand the cause.
A female with male-patternhairloss (AGA) is seeking help after unsuccessful treatments with spironolactone and supplements, and is considering oral minoxidil and finasteride despite concerns about medication side effects. She has ruled out hormonal birth control and PRP/PRFM, and is looking into further medical advice due to abnormal lab results.
A 25-year-old male experienced significant hairloss due to telogen effluvium and androgenetic alopecia. He began using finasteride, minoxidil, and vitamins, seeing some regrowth but remains worried about hair density.
The conversation discusses how Caucasian men are more likely to experience hairloss due to genetic predisposition, with factors like the androgen receptor on the X chromosome playing a significant role. The user also expresses confusion about the evolutionary reasons for hairloss, especially in colder climates where it would seem beneficial to retain hair for warmth.
How diffuse unpatterned alopecia (DUPA) is not an invitation to self-diagnose oneself with aggressive AGA and that seeking a specialized dermatologist may help people experiencing hairloss. Treatment options discussed include topical clobetasol propionate, oral minoxidil, and discontinuing finasteride.